NHS Breast Screening Support for Very High Risk Women After Radiotherapy

BARD is a confidential English database designed to identify and support women who received radiotherapy involving breast tissue before age 36, ensuring they receive appropriate breast screening at the right time. The service implements national guidelines recommending screening commence 8 years post-radiotherapy or at age 25-30 (depending on circumstances), whichever is later. BARD manages screening appointment scheduling, monitors screening effectiveness, and handles referrals for non-lymphoma patients through consultant clinical oncologists using the dedicated referral form. This opportunity involves providing management and support services to deliver coordinated breast cancer screening to a high-risk population in line with clinical guidelines.